The broad, long-term goal of this multi-disciplinary collaborative of biomedical engineers and physician- scientists is to develop early, non-invasive methods to identify individuals at risk of developing chronic kidney disease (CKD). Current methods to detect kidney disease are only useful when more than half of the filtering units of the kidney, nephrons, are nonfunctional. Nephron number is determined at birth, declines over the lifespan of a human and is directly related to the development of chronic kidney and cardiovascular disease. Unfortunately, there are no techniques to count the total number of functioning nephrons in living individuals. Additionally, there is no way to integrate the major compartments of the kidney, such as glomerular changes to those in the vasculature or tubulointerstitial space. A diagnostic biomarker to assess renal microstructure, such as number and volume of glomeruli, could significantly benefit patients: earlier therapeutic intervention, novel endpoints for assessing renal safety in clinical trials for drug development, and for renal allografts allocation. This work has three Specific Aims: 1) We will assess the changes in the glomeruli by MRI during the development of CKD using two mouse models: a congenital reduction in nephron number and a glomerulosclerosis model of CKD. We will compare the changes in glomerular microstructure to the vascular and tubular compartments and to traditional biomarkers of renal disease. 2) We will determine the time course of tubulointerstitial pathology using MRI in mouse model representing the transition from acute kidney injury to chronic kidney disease. 3) We will determine the effect of ACE inhibition of the microstructure of the kidney in a mouse model of essential hypertension. At the conclusion of this project, we will have the first comprehensive, integrated MRI-based evaluation of the kidney, powerful data to inform the translation of these MRI-based biomarkers for future studies to predict kidney disease progression.

Public Health Relevance

The purpose of this project is to detect changes in renal microstructure in mouse models with chronic kidney disease using novel MRI techniques combined with histologic assessments and provide a comprehensive, noninvasive map of CKD progression. This work will lay the foundation for the use of contrast enhanced-MRI to study single nephron structure and function to develop therapeutics and strategies to reduce the burden of chronic kidney disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK110622-03
Application #
9898042
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Gossett, Daniel Robert
Project Start
2019-07-16
Project End
2020-08-31
Budget Start
2019-07-16
Budget End
2019-08-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Baldelomar, Edwin J; Charlton, Jennifer R; Beeman, Scott C et al. (2018) Measuring rat kidney glomerular number and size in vivo with MRI. Am J Physiol Renal Physiol 314:F399-F406
Selewski, David T; Hyatt, Dylan M; Bennett, Kevin M et al. (2018) Is acute kidney injury a harbinger for chronic kidney disease? Curr Opin Pediatr 30:236-240